BeStock  
Stocks › Biotechnology › CLYM

Climb Bio CLYM

US equityMarket cap rank #3548Biotechnology
$9.19 −$0.09 (-0.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.03 -1.76%
Open$8.98
Prev close$9.28
Day range$8.90 – $9.40
Volume770.2K
Market cap$539.80M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.8x
CheapRich

Below its usual level · 25th percentile, 5-year average -10.5x

Price / book2.7x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average 1.4x

#3576 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-131x-79x-28x23xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$12.49
Price vs. fair value-26.4%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.67 – 1.36 87% (pricier than usual) #3576 of 5329 (1 = cheapest)
PE -12.79 -7.85 -10.50 25% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CLYM.

Sign in to join the discussion.

Scroll to Top